(Q37182188)

18 August 2017

Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas (English)

1 reference

18 August 2017

A Akiyama-Abe

1

1 reference

18 August 2017

T Minaguchi

2

1 reference

18 August 2017

Y Nakamura

3

1 reference

18 August 2017

H Michikami

4

1 reference

18 August 2017

A Shikama

5

1 reference

18 August 2017

S Nakao

6

1 reference

18 August 2017

M Sakurai

7

1 reference

18 August 2017

H Ochi

8

1 reference

18 August 2017

M Onuki

9

1 reference

18 August 2017

K Matsumoto

10

1 reference

18 August 2017

T Satoh

11

1 reference

18 August 2017

A Oki

12

1 reference

18 August 2017

H Yoshikawa

13

1 reference

18 August 2017

language of work or name

English

0 references

publication date

15 August 2013

1 reference

British Journal of Cancer

18 August 2017

1 reference

18 August 2017

109

1 reference

18 August 2017

6

1 reference

18 August 2017

1703-1710

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2013.455

18 August 2017

0 references

cites work

Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776978

Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776978

Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776978

PIK3CA mutation associates with improved outcome in breast cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776978

Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776978

A knotty turnabout?: Akt1 as a metastasis suppressor

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776978

Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776978

Insulin-like growth factor-I inhibits cell growth in the a549 non-small lung cancer cell line

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776978

PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776978

Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776978

Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776978

PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776978

PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23949151

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23949151

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mutational Analysis of thePTENGene in Endometrial Carcinoma and Hyperplasia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23949151

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2013.455

1 reference

18 August 2017

1 reference

18 August 2017

1 reference